Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESAB CorpESAB · Entity 3958 | Chief Financial Officer | March 09, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESAB Corp
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 32,561 |
Ending reported balance
After 2026-03-09 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-09 · Exercise / conversion · Acquired 2,006 · Balance 29,692 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Row 2 · 2026-03-09 · Tax withholding · Disposed 986 · Balance 28,706 F2: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Row 3 · 2026-03-09 · Grant · Acquired 7,582 · Balance 36,288 F3: Represents shares vested pursuant to performance-based restricted stock units granted on March 8, 2023, which vesting was subject to the certification of certain performance criteria. The award vested on March 8, 2026. Row 4 · 2026-03-09 · Tax withholding · Disposed 3,727 · Balance 32,561 F4: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of performance-based restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-03-08 | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-09 · Exercise / conversion · Disposed 2,006 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F5: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on March 8, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
F2: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability.
F3: Represents shares vested pursuant to performance-based restricted stock units granted on March 8, 2023, which vesting was subject to the certification of certain performance criteria. The award vested on March 8, 2026.
F4: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of performance-based restricted stock units. No shares were sold by the reporting person to satisfy this tax liability.
F5: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on March 8, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 9,139 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 6 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,139 Underlying: Common stock, par value $0.001 · 9,139 shares Expires 2026-02-24 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 5,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 5 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,133 Underlying: Common stock, par value $0.001 · 5,133 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 4 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,779 Underlying: Common stock, par value $0.001 · 1,779 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 1,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 3 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common stock, par value $0.001 · 1,823 shares Expires 2023-07-25 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 2 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 798 Underlying: Common stock, par value $0.001 · 798 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC | ESAB Corp ESAB · Entity 3958 | GrantCommon stock, par value $0.001 | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · nonDerivative · entry 1 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,092 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.